NeuBase Therapeutics, Inc. ( NBSE) - Stock Earnings
Stock symbol NBSE is outdated, potentially delisted? Maybe it is available on other exchange?
NBSE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -4.0 million USD | — USD |
| 2023Q2 | -3.4 million USD | — USD |
| 2023Q3 | -1.8 million USD | — USD |
NBSE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -17.3 million USD | 0 USD |
| 2021 | -25.7 million USD | 0 USD |
| 2022 | -34.2 million USD | 0 USD |
NBSE
Price: $0.38
52 week price:
Earnings Per Share: -18.60 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 97523
Market Capitalization: 1.4 million